202 related articles for article (PubMed ID: 25597396)
61. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
62. Capicua restricts cancer stem cell-like properties in breast cancer cells.
Yoe J; Kim D; Kim S; Lee Y
Oncogene; 2020 Apr; 39(17):3489-3506. PubMed ID: 32108163
[TBL] [Abstract][Full Text] [Related]
63. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
64. Self-renewal as a therapeutic target in human colorectal cancer.
Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
[TBL] [Abstract][Full Text] [Related]
65. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer.
Zhang T; Li X; He Y; Wang Y; Shen J; Wang S; You Q; Zhai J; Shen L
Gastric Cancer; 2022 Mar; 25(2):346-359. PubMed ID: 34724589
[TBL] [Abstract][Full Text] [Related]
66. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
67. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
[TBL] [Abstract][Full Text] [Related]
68. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
[TBL] [Abstract][Full Text] [Related]
69. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome.
Biondani G; Zeeberg K; Greco MR; Cannone S; Dando I; Dalla Pozza E; Mastrodonato M; Forciniti S; Casavola V; Palmieri M; Reshkin SJ; Cardone RA
FEBS J; 2018 Jun; 285(11):2104-2124. PubMed ID: 29660229
[TBL] [Abstract][Full Text] [Related]
70. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
[TBL] [Abstract][Full Text] [Related]
71. Heterogeneity of tumor cells in terms of cancer-initiating cells.
Morii E
J Toxicol Pathol; 2017 Jan; 30(1):1-6. PubMed ID: 28190919
[TBL] [Abstract][Full Text] [Related]
72. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization.
Provenzano PP; Inman DR; Eliceiri KW; Trier SM; Keely PJ
Biophys J; 2008 Dec; 95(11):5374-84. PubMed ID: 18775961
[TBL] [Abstract][Full Text] [Related]
73. Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin-mediated interactions.
Gardelli C; Russo L; Cipolla L; Moro M; Andriani F; Rondinone O; Nicotra F; Sozzi G; Bertolini G; Roz L
Cancer Sci; 2021 Jan; 112(1):217-230. PubMed ID: 33068069
[TBL] [Abstract][Full Text] [Related]
74. Fibril bending stiffness of 3D collagen matrices instructs spreading and clustering of invasive and non-invasive breast cancer cells.
Sapudom J; Kalbitzer L; Wu X; Martin S; Kroy K; Pompe T
Biomaterials; 2019 Feb; 193():47-57. PubMed ID: 30554026
[TBL] [Abstract][Full Text] [Related]
75. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
[TBL] [Abstract][Full Text] [Related]
76. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
[TBL] [Abstract][Full Text] [Related]
77. Stromal alterations in ovarian cancers via wavelength dependent Second Harmonic Generation microscopy and optical scattering.
Tilbury KB; Campbell KR; Eliceiri KW; Salih SM; Patankar M; Campagnola PJ
BMC Cancer; 2017 Feb; 17(1):102. PubMed ID: 28166758
[TBL] [Abstract][Full Text] [Related]
78. Collagen density promotes mammary tumor initiation and progression.
Provenzano PP; Inman DR; Eliceiri KW; Knittel JG; Yan L; Rueden CT; White JG; Keely PJ
BMC Med; 2008 Apr; 6():11. PubMed ID: 18442412
[TBL] [Abstract][Full Text] [Related]
79. Maspin influences response to doxorubicin by changing the tumor microenvironment organization.
Triulzi T; Ratti M; Tortoreto M; Ghirelli C; Aiello P; Regondi V; Di Modica M; Cominetti D; Carcangiu ML; Moliterni A; Balsari A; Casalini P; Tagliabue E
Int J Cancer; 2014 Jun; 134(12):2789-97. PubMed ID: 24242003
[TBL] [Abstract][Full Text] [Related]
80. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
